JPH0357084B2 - - Google Patents
Info
- Publication number
- JPH0357084B2 JPH0357084B2 JP57029816A JP2981682A JPH0357084B2 JP H0357084 B2 JPH0357084 B2 JP H0357084B2 JP 57029816 A JP57029816 A JP 57029816A JP 2981682 A JP2981682 A JP 2981682A JP H0357084 B2 JPH0357084 B2 JP H0357084B2
- Authority
- JP
- Japan
- Prior art keywords
- collagenase
- agent
- kit
- buffer
- protease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 102000029816 Collagenase Human genes 0.000 claims description 52
- 108060005980 Collagenase Proteins 0.000 claims description 52
- 229960002424 collagenase Drugs 0.000 claims description 48
- 239000003795 chemical substances by application Substances 0.000 claims description 32
- 239000004365 Protease Substances 0.000 claims description 31
- 102000035195 Peptidases Human genes 0.000 claims description 24
- 108091005804 Peptidases Proteins 0.000 claims description 24
- 230000000694 effects Effects 0.000 claims description 21
- 108090000631 Trypsin Proteins 0.000 claims description 18
- 102000004142 Trypsin Human genes 0.000 claims description 18
- 210000004262 dental pulp cavity Anatomy 0.000 claims description 18
- 239000012588 trypsin Substances 0.000 claims description 18
- 239000000872 buffer Substances 0.000 claims description 17
- 102000004190 Enzymes Human genes 0.000 claims description 16
- 108090000790 Enzymes Proteins 0.000 claims description 16
- 229940088598 enzyme Drugs 0.000 claims description 16
- 235000019419 proteases Nutrition 0.000 claims description 15
- 239000012190 activator Substances 0.000 claims description 7
- 239000002131 composite material Substances 0.000 claims description 7
- 239000008363 phosphate buffer Substances 0.000 claims description 7
- 108090000317 Chymotrypsin Proteins 0.000 claims description 6
- 108090000526 Papain Proteins 0.000 claims description 6
- 108090000284 Pepsin A Proteins 0.000 claims description 6
- 102000057297 Pepsin A Human genes 0.000 claims description 6
- 239000007853 buffer solution Substances 0.000 claims description 6
- 229960002376 chymotrypsin Drugs 0.000 claims description 6
- 229940055729 papain Drugs 0.000 claims description 6
- 235000019834 papain Nutrition 0.000 claims description 6
- 229940111202 pepsin Drugs 0.000 claims description 6
- 229960001322 trypsin Drugs 0.000 claims description 4
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 claims description 3
- 239000007983 Tris buffer Substances 0.000 claims description 3
- 239000011575 calcium Substances 0.000 claims description 3
- 229910001424 calcium ion Inorganic materials 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims description 3
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 claims description 2
- 229910001425 magnesium ion Inorganic materials 0.000 claims description 2
- 230000003213 activating effect Effects 0.000 claims 2
- 239000002075 main ingredient Substances 0.000 claims 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical group [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims 1
- 159000000007 calcium salts Chemical group 0.000 claims 1
- 159000000003 magnesium salts Chemical class 0.000 claims 1
- 239000000243 solution Substances 0.000 description 17
- 102000008186 Collagen Human genes 0.000 description 15
- 108010035532 Collagen Proteins 0.000 description 15
- 239000003708 ampul Substances 0.000 description 15
- 229920001436 collagen Polymers 0.000 description 15
- 210000004416 odontoblast Anatomy 0.000 description 14
- 241000283690 Bos taurus Species 0.000 description 9
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 9
- 239000001110 calcium chloride Substances 0.000 description 8
- 229910001628 calcium chloride Inorganic materials 0.000 description 8
- 235000011148 calcium chloride Nutrition 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 239000000835 fiber Substances 0.000 description 7
- 238000004140 cleaning Methods 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 239000002504 physiological saline solution Substances 0.000 description 4
- 238000000635 electron micrograph Methods 0.000 description 3
- 238000001493 electron microscopy Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 210000004268 dentin Anatomy 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 230000010534 mechanism of action Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 239000008055 phosphate buffer solution Substances 0.000 description 2
- SXAMGRAIZSSWIH-UHFFFAOYSA-N 2-[3-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1,2,4-oxadiazol-5-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1=NOC(=N1)CC(=O)N1CC2=C(CC1)NN=N2 SXAMGRAIZSSWIH-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 241000187254 Actinomadura madurae Species 0.000 description 1
- 102000004400 Aminopeptidases Human genes 0.000 description 1
- 108090000915 Aminopeptidases Proteins 0.000 description 1
- 240000006439 Aspergillus oryzae Species 0.000 description 1
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 108010004032 Bromelains Proteins 0.000 description 1
- 102000005367 Carboxypeptidases Human genes 0.000 description 1
- 108010006303 Carboxypeptidases Proteins 0.000 description 1
- 102000005600 Cathepsins Human genes 0.000 description 1
- 108010084457 Cathepsins Proteins 0.000 description 1
- 102000005593 Endopeptidases Human genes 0.000 description 1
- 108010059378 Endopeptidases Proteins 0.000 description 1
- 102000018389 Exopeptidases Human genes 0.000 description 1
- 108010091443 Exopeptidases Proteins 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- RSYYQCDERUOEFI-JTQLQIEISA-N N-benzoyl-L-arginine Chemical compound NC(=N)NCCC[C@@H](C(O)=O)NC(=O)C1=CC=CC=C1 RSYYQCDERUOEFI-JTQLQIEISA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241001135223 Prevotella melaninogenica Species 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- 241000223238 Trichophyton Species 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 235000019835 bromelain Nutrition 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940066758 endopeptidases Drugs 0.000 description 1
- 239000003248 enzyme activator Substances 0.000 description 1
- YQDHCCVUYCIGSW-LBPRGKRZSA-N ethyl (2s)-2-benzamido-5-(diaminomethylideneamino)pentanoate Chemical compound NC(=N)NCCC[C@@H](C(=O)OCC)NC(=O)C1=CC=CC=C1 YQDHCCVUYCIGSW-LBPRGKRZSA-N 0.000 description 1
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- -1 fuicin Proteins 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 239000008176 lyophilized powder Substances 0.000 description 1
- 230000002132 lysosomal effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 150000003017 phosphorus Chemical class 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000001878 scanning electron micrograph Methods 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000012089 stop solution Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Dental Preparations (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57029816A JPS58148828A (ja) | 1982-02-27 | 1982-02-27 | 歯根管処理剤並びに同処理用キツト |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57029816A JPS58148828A (ja) | 1982-02-27 | 1982-02-27 | 歯根管処理剤並びに同処理用キツト |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS58148828A JPS58148828A (ja) | 1983-09-05 |
| JPH0357084B2 true JPH0357084B2 (https=) | 1991-08-30 |
Family
ID=12286539
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP57029816A Granted JPS58148828A (ja) | 1982-02-27 | 1982-02-27 | 歯根管処理剤並びに同処理用キツト |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS58148828A (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10237317B4 (de) * | 2002-08-15 | 2010-04-08 | 3M Espe Ag | Enzymhaltige Zusammensetzung, Verfahren zu deren Herstellung und deren Verwendung |
| EP1600141B1 (en) | 2004-05-24 | 2013-04-17 | 3M Deutschland GmbH | Collagenolytic active enzyme containing compositions for the treatment of dental caries |
| CN101861317B (zh) | 2007-03-29 | 2013-07-31 | A.B.英特尔法玛有限公司 | 抗组胺类抗过敏剂及其制备方法 |
| CN109152866B (zh) * | 2016-03-31 | 2021-10-15 | 国立研究开发法人国立长寿医疗研究中心 | 牙科用前处理材料及牙组织再生试剂盒 |
| JP2019063191A (ja) * | 2017-09-29 | 2019-04-25 | 国立研究開発法人国立長寿医療研究センター | 非細胞性根管充填材及び非細胞性歯組織再生促進キット |
-
1982
- 1982-02-27 JP JP57029816A patent/JPS58148828A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS58148828A (ja) | 1983-09-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Eisen et al. | Animal and human collagenases | |
| Rosen et al. | Proteases of Treponema denticola outer sheath and extracellular vesicles | |
| Figueiredo‐Pereira et al. | A new inhibitor of the chymotrypsin‐like activity of the multicatalytic proteinase complex (20S proteasome) induces accumulation of ubiquitin‐protein conjugates in a neuronal cell | |
| US9050332B2 (en) | Enzyme containing composition, process of producing said composition and its use | |
| Hannig | Effect of Carisolv™ solution on sound, demineralized and denatured dentin–an ultrastructural investigation | |
| EP0456724B1 (en) | Composition and method for treating benign prostatic hypertrophy | |
| US4749511A (en) | Contact lens cleaning solutions containing endoproteinase lys-C | |
| HK1003981B (en) | Composition and method for treating benign prostatic hypertrophy | |
| LU86875A1 (fr) | Utilisation de l'activateur tissulaire du plasminogene,son association avec une superoxyde-dismutase et formulation pharmaceutique contenant cette association | |
| JPH10505688A (ja) | コンタクトレンズの洗浄、消毒及び保存 | |
| Horsthemke et al. | Degradation of substance P by neurones and glial cells | |
| JPH08503691A (ja) | 下痢の治療における酵素、特にブロメラインの使用 | |
| Dung et al. | Degradation of insoluble bovine collagen and human dentine collagen pretreated in vitro with lactic acid, pH 4.0 and 5.5 | |
| JPH0357084B2 (https=) | ||
| Srinath et al. | Scanning Electron Microscopic Evaluation of Residual Dentin Surface in Primary Teeth After Using Two Chemo-mechanical Caries Removal Agents. An in vitro study | |
| AU5802299A (en) | Extended release acetaminophen | |
| EP0277383B1 (en) | Mouth care products | |
| Klont et al. | Degradation of bovine incisor root collagen in an in vitro caries model | |
| Polgár | Structure-function of prolyl oligopeptidase and its role in neurological disorders | |
| Pulidindi et al. | Effect of Remineralizing Agents on Resin-Dentin Bond Durability of Adhesive Restorations: An: in vitro: Study | |
| FR2520614A1 (fr) | Procede et composition utilisant la b-1,3-glucanase pour le nettoyage des dentiers | |
| US2887435A (en) | Stabilized vasoconstrictor-enzyme preparation | |
| Yamasaki et al. | Cytochemical identification of lysosomal system of the rat junctional epithelium | |
| EP0153925A1 (en) | Oral dental care composition | |
| JPH05112465A (ja) | アンギオテンシン変換酵素阻害剤含有組成物の製造方法 |